NHPC is India's premier state-owned utility that develops and operates large-scale hydroelectric power plants, selling bulk electricity to state utilities under long-term contracts.
The company possesses a narrow moat derived from regulatory licenses and significant cost/scale advantages in hydroelectric development. While it maintains high net margins (36%), the moat is constrained by low returns on capital (8.4% ROCE) and chronic project delays that erode reinvestment value.
Earnings are primarily reinvested into massive, multi-decade infrastructure projects with significant execution risk, supplemented by a consistent dividend payout policy (approx. 44% of PAT).
Five years out, the investment collapsed as chronic execution delays at Subansiri Lower and Parbati-II transitioned from 'routine' to 'catastrophic,' with geological surprises and climate-driven flash floods permanently impairing the asset base. The reliance on regulatory deferral accounts to mask stagnant cash flows finally broke when regulators refused to pass on massive cost overruns to consumers, leading to a liquidity crunch. As debt servicing costs climbed against a backdrop of non-existent EPS growth, the market re-rated the firm from a growth utility to a distressed infrastructure play, realizing the capital was trapped in non-productive, silted-up projects.
RichFakir rates NHPC Ltd's business quality as poor — 38/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, NHPC Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on NHPC Ltd is: Not rated. A poor business at an expensive price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of NHPC Ltd's fair value is about ₹28 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →